Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1DEXMEDETOMIDINE1件: Dexmedetomidine2件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬13件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280
2Dexmedetomidine 11件: Dexmedetomidine2件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280
3Dexmedetomidine 21件: Dexmedetomidine2件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280
4Dexmedetomidine 31件: Dexmedetomidine2件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280
5Dexmedetomidine group1件: Dexmedetomidine2件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70
6DEXMEDETOMIDINE HYDROCHLORIDE1件: Dexmedetomidine2件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70
7Dexmedetomidine Hydrochloride Infusion1件: Dexmedetomidine2件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6
8Dexmedetomidine with ropivacaine2件: Dexmedetomidine,
Ropivacaine		4件: D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride),
D04048 ,
D08490 		8件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70
9Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		4件: D00320 ,
D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride),
D01399 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215
10Scopolamine, atropine, edaravone and dexmedetomidine4件: Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		9件: D00113 ,
D00138 ,
D00514 (Name: Dexmedetomidine),
D01077 ,
D01205 (Name: Dexmedetomidine hydrochloride),
D01552 ,
D02069 ,
D03011 ,
D03814 		8件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2